Minerva Neurosciences (NERV) Shares Outstanding (2013 - 2026)

Minerva Neurosciences' Shares Outstanding (Entity) history runs 14 years deep, the most recent figure standing at $43.8 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 526.9% year-over-year to $43.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43.8 million (up 526.9% YoY) and the FY2025 annual result came in at $8.5 million, up 21.02% from the prior year.
• Shares Outstanding (Entity) was $43.8 million for Q1 2026 at Minerva Neurosciences, up from $8.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $43.8 million in Q1 2026 and bottomed at $5.3 million in Q2 2022.
• A 5-year average of $8.7 million and a median of $7.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) decreased 0.0% — and 2026, when it jumped 526.9%.
• Minerva Neurosciences' Shares Outstanding (Entity) stood at $5.3 million in 2022, then surged by 30.96% to $7.0 million in 2023, then changed by 0.0% to $7.0 million in 2024, then increased by 21.02% to $8.5 million in 2025, then surged by 418.01% to $43.8 million in 2026.
• Business Quant data shows NERV's Shares Outstanding (Entity) at $43.8 million in Q1 2026, $8.5 million in Q4 2025, and $7.0 million in Q3 2025.